FRANCISCO JAVIER LÓPEZ LONGO-rekin lankidetzan egindako argitalpenak (10)

2012

  1. Autoanticuerpos en las enfermedades autoinmunes sistémicas

    Ergon

2010

  1. Interleucinas en la fisiopatología de la artritis reumatoide: más allá de las citocinas proinflamatorias

    Reumatologia Clinica, Vol. 6, Núm. SUPPL. 3

  2. Long-term remission of severe refractory dermatopolymyositis with a weekly-scheme of immunoglobulin followed by rituximab therapy

    Rheumatology International, Vol. 30, Núm. 6, pp. 817-819

2009

  1. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

    Arthritis Care and Research, Vol. 61, Núm. 4, pp. 419-424

  2. The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: Do they imply new risk factors?

    Drug News and Perspectives, Vol. 22, Núm. 9, pp. 543-548

2006

  1. Anti-cyclic citrullinated peptide versus anti-Sa antibodies in diagnosis of rheumatoid arthritis in an outpatient clinic for connective tissue disease and spondyloarthritis

    Journal of Rheumatology, Vol. 33, Núm. 8, pp. 1476-1481

  2. Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis

    Arthritis Care and Research, Vol. 55, Núm. 4, pp. 657-661

  3. Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy

    Lupus, Vol. 15, Núm. 12, pp. 881-885

2005

  1. Discordance between anti-β2-glycoprotein-I and anti-cardiolipin antibodies in patients with clinical criteria of antiphospholipid syndrome

    Clinical and Experimental Rheumatology, Vol. 23, Núm. 4, pp. 525-528

  2. Prevalence of IgG anti-α-fodrin antibodies in Sjögren's syndrome

    Annals of the New York Academy of Sciences